ESTUDIO WHI, REVISTA DE MENOPAUSIA, SALUD, REVISTAS MÉDICAS. Actualidad Inmediata Debido a la importancia de esta investigación y al impacto en. WHI. Progestin. Estrogen. Tibolone. Cardiovascular disease. Tromboembolic disease . Boletín de la Asociación Española para el Estudio de la Menopausia, . Los trastornos de la menopausia pueden ser evitados y combatidos Sin embargo, recientes estudios, como el estudio WHI, han puesto en duda los beneficios.
|Published (Last):||22 September 2016|
|PDF File Size:||17.17 Mb|
|ePub File Size:||2.57 Mb|
|Price:||Free* [*Free Regsitration Required]|
Indeed, the study demonstrated a significant smaller coronary calcium score a lower calcified-plaque burden in women who used estrogen during the WHI trial as compared to those who were allocated to the placebo arm . J Clin Oncol, 18pp.
There was a problem providing the content you requested
There is no reason to avoid postmenopause hormone medication when indicated and not contra-indicated. Hum Reprod, 16pp. In addition, the telephone-administered cognitive battery showed adequate construct validity. Effects of genistein and hormone-replacement therapy on bone wui in early postmenopausal women: Obstet Gynecol,pp.
Amer J Clin Nutr, 78pp. Are you a health professional able to prescribe or dispense drugs? Women’s Health Initiative Investigators.
The effects of soy-derived phytoestrogens on serum lipids and lipoproteins in moderately hypercholesterolemic postmenopausal women. Menopause, 7pp.
Efficacy of menopauisa soy rich diet in preventing postmenopausal osteoporosis. Am J Cardiol, 85pp. J Clin Endocrinol Metab, 89pp. Maturitas, 42pp. In a re-analysis of HERS follow-up during 6.
Home – IMS – International Menopause Society
Phytoestrogens for treatment of menopausal symptoms: Fertil Steril, 77pp. Van der Schow, P. It must be made clear that the concept of HRT does not mean that all postmenopausal women must be always under hormonal treatments [ 11 and 12 ].
Urinary excretion of phytoestrogens and risk of breast cancer among Chinese women in Shangai. Risk and benefits of estrogen plus progestin in healty postmenopausal women. Maturitas, 45pp. Failure of estrogen plus progestin therapy for prevention.
Furberg CD, et al. Flaxseed dietary supplement versus hormone replacement therapy in hypercholesterolemic menopausal women. Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine in the perimenopausal women. The effect of a soy rich diet on the vaginal epithelium in postmenopause: The important issue after all is not the improperly named hormone replacement therapy [ 10 ].
Dietary phytoestrogens and their effect on bone: The increased risk of breast cancer became apparent only after the fourth year of treatment. During the trial women in the estrogen plus progestin group and in the placebo group had an hysterectomy [ 1 ]. Intern J Cancer, 81pp.
The order of magnitude of the relative risks is impressive. Flaxseed improves lipid profile without altering biomarkers of bone metabolism in postmenopausal women.
Estrogen plus progestin and the risk of coronary heart disease. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. The Management of the Menopause.
Which clinical studies provide the best evidence?
The incidence of side effects was really very, very small in terms of individual health. Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women.
Menopause, 8pp. Mammalian lignans and phytoestrogens. The recommendation of WHI Committee is that continuous estrogen plus progestin should not be used even for the primary prevention of heart disease, and that they only should be used for the relief of vasomotor symptoms!
Maturitas in press. Postmenopausal hormone therapy and the risk of cardiovascular disease: The authors raised two important questions that need attention.
Isoflavonas y menopausia | Clínica e Investigación en Ginecología y Obstetricia
Although there are no results yet from this ongoing study, it already carries an important message. More recent epidemiological studies continue to supply evidence that long-term postmenopausal hormone therapy may reduce the risk for CAD in healthy women.
Phytoestrogens supplements for the treatment of hot flashes: Cardiovascular disease outcomes during 6. Recent studies on their formation, metabolism, and biological role in health and disease. Editorial JAMA ahi 3: